CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Prof. Dr. CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Prof. Dr.  CARMINA MONTOLIU, UNIVERSIDAD DE VALENCIA/INCLIVA,  Spain.

Carmina Montoliu Felix, a Valencia-born scientist and educator, is a distinguished Catedrática de Universidad at the Universidad de Valencia, specializing in Cellular Biology and Pathology. With a strong foundation in biomedical sciences and a dual role in both academia and clinical research through INCLIVA, she has become a key figure in translational medicine in Spain. Her work focuses on uncovering cellular mechanisms of disease, supported by national recognition such as her Group A classification by ISCIII. With extensive contributions indexed on platforms like ORCID and Scopus, she has gained international visibility and continues to influence the fields of pathology and biomedicine.

Profile

Orcid

 

🎓 Early Academic Pursuits

Carmina Montoliu Felix was born in Valencia, where she also pursued her academic career rooted in the life sciences. Her early interest in biology and medical sciences led her through a rigorous academic pathway that would eventually shape her into a leading figure in cellular pathology. With a profound dedication to understanding human disease at the cellular level, she cultivated a strong foundation in biology, which became the cornerstone of her future specialization in Cellular Biology and Pathology. These formative years instilled in her a passion for translational research, which continues to drive her work.

🏛️ Professional Endeavors

Currently serving as a Catedrática de Universidad at the Facultad de Medicina y Odontología of the Universidad de Valencia, Carmina Montoliu Felix holds a prestigious position within the Departamento de Patología, specifically in the Unidad de Biología. She achieved this distinguished academic rank on November 3, 2023, under BOE nº 274, a recognition of her academic excellence and contributions to higher education. Alongside her academic post, she is also an investigadora adscrita at the Fundación INCLIVA, playing a dual role in both teaching and active biomedical research. Her employment reflects the seamless integration between university instruction and clinical research aimed at improving patient outcomes.

🧬 Contributions and Research Focus

Carmina Montoliu Felix has been a pivotal contributor to the field of Cellular Biology, with specific expertise in Pathology (Área 661). Since February 29, 2012, she has been classified as a Group A Researcher within the Instituto de Salud Carlos III (ISCIII) framework. Her research activities are aligned with the Programa de Estabilización de Investigadores and the Sistema Nacional de Salud (I3SNS), focusing on intensifying biomedical research and fostering translational discoveries. Her scientific work is characterized by its interdisciplinary nature and commitment to uncovering the molecular basis of diseases, contributing significantly to both national and international health research landscapes.

🏅 Accolades and Recognition

Dr. Montoliu Felix’s academic excellence has been affirmed through numerous accolades, including the Group A classification by the Comisión Técnica de Evaluación de Recursos Humanos del ISCIII, one of the highest distinctions for biomedical researchers in Spain. Her appointment as a full professor is a testament to her leadership in medical education and scientific research. She is widely recognized among her peers for her scholarly impact, rigor, and commitment to nurturing future scientists and medical professionals.

🌍 Impact and Influence

Her work not only resonates within academic circles but also extends into clinical research through her active role at INCLIVA. By integrating research and practice, Carmina Montoliu Felix exemplifies how scientific inquiry can lead to tangible health benefits. Her influence spans collaborations with national healthcare systems and academic institutions, reinforcing her role as a key figure in the biomedical field. Through platforms such as ORCID and Scopus (ORCID ID: 0000-0002-4740-4788; Scopus ID: 6701923138), her contributions are accessible globally, further amplifying her scientific impact.

🔬 Legacy and Future Contributions

With a career marked by consistent advancement and dedication to discovery, Carmina Montoliu Felix is poised to continue shaping the future of cellular pathology and biomedical research in Spain and beyond. Her dual engagement in academia and clinical research ensures that her legacy will include both scientific breakthroughs and a generation of inspired students and researchers. Looking ahead, she is expected to further expand the integration of molecular biology into clinical diagnostics, ultimately improving patient care through science.

📚 A Life Committed to Science and Society

Beyond her technical expertise and professional roles, Carmina Montoliu Felix embodies the ideals of a scholar deeply committed to the betterment of society through science. Her residence and professional base in Valencia, her continuous academic contributions, and her service within public institutions paint the portrait of a researcher who bridges the lab and the community. Through her enduring efforts, she not only advances knowledge but also enhances the collective understanding of human health and disease.

Publication

  • Title: Valproate Damaging Effect on Erythrocyte Metabolism as a Decisive Factor in the Development of Encephalopathy
    Authors: Lyudmila Tikhonova; Eugene Maevsky; Carmina Montoliu; Elena Kosenko
    Year: 2025

 

  • Title: Ammoniagenic Action of Valproate without Signs of Hepatic Dysfunction in Rats: Possible Causes and Supporting Evidence
    Authors: Gubidat Alilova; Lyudmila Tikhonova; Carmina Montoliu; Elena Kosenko
    Year: 2024

 

  • Title: Automatic Video-Oculography System for Detection of Minimal Hepatic Encephalopathy Using Machine Learning Tools
    Authors: Alberto Calvo Córdoba; Cecilia Elisabet García Cena; Carmina Montoliu
    Year: 2023

 

  • Title: Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients
    Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Amparo Urios; MP Ballester; Teresa San-Miguel; Javier Megías Vericat; Elena Kosenko; Tosca J; Maria-Pilar Rios et al.
    Year: 2023

 

  • Title: Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease
    Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Carla Giménez-Garzó; Amparo Urios; MP Ballester; Lucia Durbán; Maria-Pilar Rios; Javier Megías Vericat; Teresa San-Miguel et al.
    Year: 2023

 

  • Title: Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer’s Disease
    Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
    Year: 2023

 

  • Title: Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy
    Authors: Juan José Gallego; Alessandra Fiorillo; Franc Casanova-Ferrer; Amparo Urios; MP Ballester; Lucia Durbán; Javier Megías; Teresa Rubio; Andrea Cabrera-Pastor; Desamparados Escudero-García et al.
    Year: 2022

 

  • Title: Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression
    Authors: Teresa San-Miguel; Javier Megías; Daniel Monleon; Lara Navarro Cerveró; Lisandra Muñoz; Carmina Montoliu; Marina Meri; Pedro Roldán; Miguel Cerdá-Nicolás; Concha López-Ginés
    Year: 2022

 

  • Title: Is NMDA-Receptor-Mediated Oxidative Stress in Mitochondria of Peripheral Tissues the Essential Factor in the Pathogenesis of Hepatic Encephalopathy?
    Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
    Year: 2022

 

  • Title: A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease
    Authors: Carla Giménez-Garzó; Alessandra Fiorillo; MP Ballester; Juan José Gallego Roig; Franc Casanova-Ferrer; Amparo Urios; Salvador Benlloch; Marti-Aguado D; Teresa San-Miguel; Tosca J et al.
    Year: 2021

 

Conclusion

Carmina Montoliu Felix’s career reflects a rare blend of scientific rigor, academic leadership, and social impact. Her journey from student to full professor showcases her dedication to advancing both knowledge and healthcare. As she continues to lead research at the intersection of cellular biology and clinical application, her legacy will not only be measured in published studies and prestigious titles, but also in the real-world health outcomes and inspired minds her work cultivates. Her future contributions promise to deepen our understanding of disease and strengthen the bridge between science and society.

 

kaveh Rahimi | Gut–Brain Axis | Excellence in Research

Dr. kaveh Rahimi | Gut brain axis | Excellence in Research

Dr. kaveh rahimi, shahid chamran university of ahvaz, Iran.

Dr. Kaveh Rahimi, an academic staff member at Shahid Chamran University of Ahvaz, holds a Ph.D. in Physiology. His research primarily focuses on the gut-brain axis, exploring the effects of fecal microbiota transplantation on ulcerative colitis models in rats. Through his professional journey, he has made significant contributions to physiological sciences, with impactful publications in ISI-indexed journals and a Scopus H-index of 10. His work bridges experimental research with clinical applications, aiming to enhance the understanding of gut-related disorders and their neurological implications.

Profile

Orcid

📚 Early Academic Pursuits

Dr. Kaveh Rahimi’s academic journey began with a profound interest in the intricate mechanisms of human physiology, which led him to pursue a Ph.D. in Physiology. His early education laid a strong foundation in biomedical sciences, fostering a deep curiosity about the complex interactions within the human body. This passion guided him through rigorous academic training, where he developed expertise in physiological processes, particularly those associated with the gut-brain axis. His dedication to academic excellence and scientific inquiry set the stage for a distinguished career in research and education.

🏫 Professional Endeavors

Currently serving as an academic staff member at Shahid Chamran University of Ahvaz, Dr. Rahimi has established himself as a committed educator and researcher. His professional journey is marked by significant contributions to the field of physiology through teaching, mentoring, and leading research initiatives. Dr. Rahimi’s role extends beyond the classroom, encompassing project administration, supervision, and formal analysis. His ability to integrate academic knowledge with practical research has made him a pivotal figure in his institution, inspiring both colleagues and students alike.

🔬 Contributions and Research Focus

Dr. Rahimi’s research is deeply rooted in the exploration of the gut-brain axis, a field that unveils the complex communication pathways between the gastrointestinal tract and the central nervous system. His notable project on the “Effect of Fecal Microbiota Transplantation on Ulcerative Colitis Model in Rats” highlights his innovative approach to understanding this dynamic interaction. Through meticulous methodology and investigation, he has contributed significantly to the scientific community’s understanding of how gut health influences neurological functions. His collaborative work with Mahdis Morshedbak and Mohammad Reza Tabandeh has further enriched the depth and scope of his research.

🏆 Accolades and Recognition

Dr. Rahimi’s scholarly contributions have earned him recognition within the scientific community, reflected in his Scopus H-index of 10, indicating a substantial impact of his research publications. His work has been featured in prestigious ISI-indexed journals, showcasing the relevance and quality of his scientific endeavors. These achievements underscore his dedication to advancing physiological research and highlight his role as a thought leader in the study of the gut-brain axis.

🌍 Impact and Influence

The influence of Dr. Rahimi’s work extends beyond academia, contributing to the broader understanding of gut-related disorders and their neurological implications. His research findings have the potential to inform clinical practices, particularly in the treatment of conditions like ulcerative colitis. By bridging the gap between experimental research and practical applications, Dr. Rahimi has positioned himself as an influential figure in both scientific and medical communities.

🔗 Legacy and Future Contributions

Dr. Rahimi’s legacy is defined by his unwavering commitment to scientific exploration and education. As he continues to delve deeper into the complexities of the gut-brain axis, his future contributions are poised to shape new therapeutic strategies and enhance the scientific understanding of physiological interconnections. His dedication to mentorship ensures that his influence will resonate through the next generation of researchers, perpetuating a cycle of knowledge, discovery, and innovation.

Publication

  • Title: Effect of fecal microbiota transplantation on ulcerative colitis model in rats: The gut–brain axis
    Authors: Mahdis Morshedbak, Kaveh Rahimi, Mohammad Reza Tabandeh
    Year: 2025

 

  • Title: Effects of dimethyl itaconate on expressions of NGFI-A and NGFI-B and inflammatory cytokines in the spinal cord in the formalin test
    Authors: Kaveh Rahimi, Mohammad Abbaszadeh, Sharareh Bakhtazad, Zohreh Ghotbeddin
    Year: 2024

 

  • Title: The protective effects of Gamma-linolenic acid against indomethacin-induced gastric ulcer in rats
    Authors: Kaveh Rahimi, Masoumeh Ezzati Givi, Anahita Rezaie, Mohammad Hekmatmanesh, Yasamin Shaker Ardakani
    Year: 2024

 

  • Title: The impact of Dimethyl itaconate on c-Fos expression in the spinal cord in experimental pain models
    Authors: Mohammad Abbaszadeh, Zohreh Ghotbeddin, Mohammad Reza Tabandeh, Kaveh Rahimi
    Year: 2024

 

  • Title: Fish oil ameliorates ethanol-induced gastric injury in rat by modulating gene related to apoptosis
    Authors: Nikoo Parham, Kaveh Rahimi, Zohreh Ghotbeddin, Mohammad Reza Tabandeh
    Year: 2024

 

  • Title: Ameliorative effect of Stevia rebaudiana Bertoni on sperm parameters, in vitro fertilization, and early embryo development in a streptozotocin-induced mouse model of diabetes
    Authors: Mahdad Abdi, Fathemeh Alizadeh, Erfan Daneshi, Morteza Abouzaripour, Fardin Fathi, Kaveh Rahimi
    Year: 2023

 

  • Title: The effects of alpha-pinene on the Nrf2-HO1 signaling pathway in gastric damage in rats
    Authors: Kaveh Rahimi, Negin Shirvani, Parham Sanaie, Arian Javadi, Mahsa Khademi
    Year: 2023

 

  • Title: Analgesic Effects of Alpha-Pinene on Pain Models of Writing and Plantar Tests in Rats
    Authors: K. Rahimi, A. Ebrahimifar, E. Izadpanah, H. Rahmani, A. Ahmadi
    Year: 2023

 

  • Title: Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports
    Authors: Kaveh Rahimi
    Year: 2020

 

  • Title: Targeting the balance of T helper cell responses by curcumin in inflammatory and autoimmune states
    Authors: Kaveh Rahimi
    Year: 2019

 

  • Title: The effect of Evening Primrose Oil on Changes in Polycystic Ovary Syndrome Induced by Estradiol Valerate in Rat
    Authors: Kaveh Rahimi
    Year: 2018

 

  • Title: The effect of intracerebroventricular injection of CGRP on pain behavioral responses and monoamines concentrations in the periaqueductal gray area in rat
    Authors: Kaveh Rahimi
    Year: 2018

 

Conclusion

Dr. Rahimi’s dedication to scientific research and education has positioned him as a thought leader in the field of physiology. His impactful studies on the gut-brain axis not only contribute to academic knowledge but also hold potential for advancing medical therapies. As he continues his research, Dr. Rahimi’s legacy will inspire future scientific explorations, driving innovations that benefit both the scientific community and public health.